标题
Platinum(iv) anticancer prodrugs – hypotheses and facts
作者
关键词
-
出版物
DALTON TRANSACTIONS
Volume 45, Issue 33, Pages 12983-12991
出版商
Royal Society of Chemistry (RSC)
发表日期
2016-05-24
DOI
10.1039/c6dt01414c
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
- (2016) Timothy C. Johnstone et al. CHEMICAL REVIEWS
- Potentiation of mitochondrial dysfunction in tumor cells by conjugates of metabolic modulator dichloroacetate with a Pt(IV) derivative of oxaliplatin
- (2016) Juraj Zajac et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Pt(iv) derivatives of cisplatin and oxaliplatin with phenylbutyrate axial ligands are potent cytotoxic agents that act by several mechanisms of action
- (2016) Raji Raveendran et al. Chemical Science
- Chalcoplatin, a dual-targeting and p53 activator-containing anticancer platinum(iv) prodrug with unique mode of action
- (2015) Lili Ma et al. CHEMICAL COMMUNICATIONS
- Integrin-targeted delivery into cancer cells of a Pt(iv) pro-drug through conjugation to RGD-containing peptides
- (2015) Anna Massaguer et al. DALTON TRANSACTIONS
- The Prodrug Platin-A: Simultaneous Release of Cisplatin and Aspirin
- (2014) Rakesh K. Pathak et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- The ligation of aspirin to cisplatin demonstrates significant synergistic effects on tumor cells
- (2014) Qinqin Cheng et al. CHEMICAL COMMUNICATIONS
- Conjugates of Cisplatin and Cyclooxygenase Inhibitors as Potent Antitumor Agents Overcoming Cisplatin Resistance
- (2014) Wilma Neumann et al. ChemMedChem
- Conjugation of Cisplatin Analogues and Cyclooxygenase Inhibitors to Overcome Cisplatin Resistance
- (2014) Wilma Neumann et al. ChemMedChem
- Different affinity of nuclear factor-kappa B proteins to DNA modified by antitumor cisplatin and its clinically ineffectivetransisomer
- (2014) Jana Kasparkova et al. FEBS Journal
- Antitumor platinum(IV) derivatives of oxaliplatin with axial valproato ligands
- (2014) Vojtech Novohradsky et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Pt(IV) Prodrugs Designed to Bind Non-Covalently to Human Serum Albumin for Drug Delivery
- (2014) Yao-Rong Zheng et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Nanoparticle Encapsulation of Mitaplatin and the Effect Thereof on In Vivo Properties
- (2013) Timothy C. Johnstone et al. ACS Nano
- Platinum(IV) Prodrugs with Haloacetato Ligands in the Axial Positions can Undergo Hydrolysis under Biologically Relevant Conditions
- (2013) Ezequiel Wexselblatt et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Maleimide-functionalised platinum(iv) complexes as a synthetic platform for targeted drug delivery
- (2013) Verena Pichler et al. CHEMICAL COMMUNICATIONS
- Antiproliferative activity of Pt(IV)-bis(carboxylato) conjugates on malignant pleural mesothelioma cells
- (2013) Manuela Alessio et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Influence of Equatorial and Axial Carboxylato Ligands on the Kinetic Inertness of Platinum(IV) Complexes in the Presence of Ascorbate and Cysteine and within DLD-1 Cancer Cells
- (2013) Catherine K. J. Chen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Novel tetracarboxylatoplatinum(iv) complexes as carboplatin prodrugs
- (2012) Hristo P. Varbanov et al. DALTON TRANSACTIONS
- Solid-phase synthesis of oxaliplatin–TAT peptide bioconjugates
- (2012) Sergey Abramkin et al. DALTON TRANSACTIONS
- Synthesis, characterization and antiproliferative activity on mesothelioma cell lines of bis(carboxylato)platinum(iv) complexes based on picoplatin
- (2012) Mauro Ravera et al. DALTON TRANSACTIONS
- Dependence of the Reduction Products of Platinum(IV) Prodrugs upon the Configuration of the Substrate, Bulk of the Carrier Ligands, and Nature of the Reducing Agent
- (2012) Marilù Sinisi et al. INORGANIC CHEMISTRY
- What do we know about the reduction of Pt(IV) pro-drugs?
- (2012) Ezequiel Wexselblatt et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Mitaplatin Increases Sensitivity of Tumor Cells to Cisplatin by Inducing Mitochondrial Dysfunction
- (2012) Xue Xue et al. MOLECULAR PHARMACEUTICS
- Conjugate of Pt(IV)–Histone Deacetylase Inhibitor as a Prodrug for Cancer Chemotherapy
- (2012) Jun Yang et al. MOLECULAR PHARMACEUTICS
- Pt(iv) analogs of oxaliplatin that do not follow the expected correlation between electrochemical reduction potential and rate of reduction by ascorbate
- (2011) Jenny Z. Zhang et al. CHEMICAL COMMUNICATIONS
- Evaluation of Platinum-Ethacrynic Acid Conjugates in the Treatment of Mesothelioma
- (2011) Ilaria Zanellato et al. ChemMedChem
- Anticancer Platinum (IV) Prodrugs with Novel Modes of Activity
- (2011) Chee Fei Chin et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Characterization of New Potential Anticancer Drugs Designed To Overcome Glutathione Transferase Mediated Resistance
- (2011) Katarina Johansson et al. MOLECULAR PHARMACEUTICS
- Phenylbutyrate inhibits homologous recombination induced by camptothecin and methyl methanesulfonate
- (2011) Gitte S. Kaiser et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- New reduction pathways for ctc-[PtCl2(CH3CO2)2(NH3)(Am)] anticancer prodrugs
- (2010) Alina Nemirovski et al. CHEMICAL COMMUNICATIONS
- The status of platinum anticancer drugs in the clinic and in clinical trials
- (2010) Nial J. Wheate et al. DALTON TRANSACTIONS
- Valproate induces DNA demethylation in nuclear extracts from adult mouse brain
- (2010) Erbo Dong et al. Epigenetics
- Short-Chain HDAC Inhibitors Differentially Affect Vertebrate Development and Neuronal Chromatin
- (2010) Daniel M. Fass et al. ACS Medicinal Chemistry Letters
- Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate
- (2009) Shanta Dhar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- Randomized, Multicenter, Phase III Trial of Heptaplatin 1-hour Infusion and 5-Fluorouracil Combination Chemotherapy Comparing with Cisplatin and 5-Fluorouracil Combination Chemotherapy in Patients with Advanced Gastric Cancer
- (2009) Kyung Hee Lee et al. Cancer Research and Treatment
- Novel Endothall-Containing Platinum(IV) Complexes: Synthesis, Characterization, and Cytotoxic Activity
- (2008) Michael R. Reithofer et al. CHEMISTRY & BIODIVERSITY
- Histone deacetylase inhibitors in cancer therapy
- (2008) Min-Jung Lee et al. CURRENT OPINION IN ONCOLOGY
- Phenylbutyrate interferes with the Fanconi anemia and BRCA pathway and sensitizes head and neck cancer cells to cisplatin
- (2008) Kyunghee Burkitt et al. Molecular Cancer
- Valproate-dependent transcriptional regulation of GLAST/EAAT1 expression: Involvement of Ying-Yang 1
- (2008) Gisela Aguirre et al. NEUROCHEMISTRY INTERNATIONAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started